Association of AGTR1 A1166C and CYP2C9∗3 Gene Polymorphisms with the Antihypertensive Effect of Valsartan

BACKGROUND: The differences in the antihypertensive treatment with angiotensin type II receptor blockers (ARBs) may be attributed to polymorphisms in genes involving drug-targeted receptor and drug metabolism. The present study aimed to investigate whether the antihypertensive effect of the ARB drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yi, Kong, Xiaomu, Jiang, Yongwei, Zhao, Meimei, Gao, Peng, Cong, Xiao, Cao, Yongtong, Ma, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957473/
https://www.ncbi.nlm.nih.gov/pubmed/35345577
http://dx.doi.org/10.1155/2022/7677252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957473/
https://www.ncbi.nlm.nih.gov/pubmed/35345577
http://dx.doi.org/10.1155/2022/7677252

Ejemplares similares